This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2010-2011.
Company Filing History:
Years Active: 2010-2011
Title: The Innovations of Matthew James Welham
Introduction
Matthew James Welham is a notable inventor based in Bristol, GB. He has made significant contributions to the field of chemistry, particularly in the development of pharmaceutical compounds. With a total of 2 patents to his name, Welham's work is recognized for its potential impact on medical science.
Latest Patents
Welham's latest patents include a chemical process for the preparation of an amido-phenoxybenzoic acid compound. This process is useful as an intermediate to compounds that activate glucokinase. The patent describes a method involving specific components defined in the description. Another significant patent is for the preparation of thiazolopyrimidines. This method outlines the preparation of a compound or a pharmaceutically acceptable salt or solvate thereof, derived from a specified compound formula.
Career Highlights
Welham is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca focuses on innovative solutions in drug development, contributing to advancements in healthcare.
Collaborations
Welham collaborates with esteemed colleagues, including Colin Thompson and Michael Butters. These partnerships enhance the research and development efforts within his field.
Conclusion
Matthew James Welham's contributions to the field of chemistry and pharmaceuticals are noteworthy. His innovative patents and collaborations reflect his commitment to advancing medical science.